Patent · US Active

Compositions and methods for the diagnosis and prognosis of mesothelioma

US9133522B2 · kind B2 · utility

0Cited by
0References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 29, 2008
Grant dateSep 15, 2015
Priority date
Expiry dateJun 1, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/178
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides nucleic acid sequences that are used for identification and diagnosis of specific cancers. The nucleic acid sequences can also be used for prognosis evaluation of a subject based on the expression profile of a biological sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.